Loading…

Browse All Grants

20,252 grants found

Filters
Reset

Showing 18,74118,760 of 20,252 grants

Completed NON-SBIR/STTR RPGS
Exploring novel SRC-regulated pathways in IDH mutant intrahepatic cholangiocarcinoma
NATIONAL CANCER INSTITUTE Fred Hutchinson Cancer Center United States 2021 – 2026

PROJECT SUMMARY/ABSTRACT Intrahepatic cholangiocarcinoma (ICC) is a highly lethal form of liver cancer which has been rising in incidence worldwide and carries a prognosis of under...

$3.82M
USD
Completed NON-SBIR/STTR RPGS
Mechanisms of adhesion and invasion in hyaluronic acid matrices
NATIONAL CANCER INSTITUTE University of California Berkeley United States 2021 – 2026

PROJECT SUMMARY/ABSTRACT Hyaluronic acid (HA) is the most abundant component of the human brain, where it serves essential structural, mechanical, and cell-instructive functions. A...

$3.41M
USD
Completed TRAINING, INSTITUTIONAL
Post-doctoral Training Program in Cancer Metabolism and Tumor-host Interactions
NATIONAL CANCER INSTITUTE Rutgers Biomedical and Health Sciences United States 2021 – 2026

Rutgers Cancer Institute of New Jersey (RCINJ) provides an outstanding environment for training in basic, clinical, behavioral or population-based cancer research and brings togeth...

$1.55M
USD
Completed OTHER RESEARCH-RELATED
Behavioral Activation for Depression in Older Adult Cancer Survivors: Pilot Randomized Control Trial and Implementation Outcomes
NATIONAL CANCER INSTITUTE Sloan-Kettering Inst Can Research United States 2021 – 2026

Project Summary/Abstract: As many as 35% of older adult cancer survivors (OACS; ≥65-years, ≥1-year post- treatment) have clinically significant depression. Presently, 64% of cancer...

$1.75M
USD
Completed NON-SBIR/STTR RPGS
Relaxed Polymerase Pausing as a Driver of Epigenetic Plasticity and Cancer Cell Invasion
NATIONAL CANCER INSTITUTE University of Rochester United States 2021 – 2026

Project Summary The development of distant metastases accounts for a significant proportion of breast cancer mortality; as many as 30% of patients initially diagnosed at an early s...

$3.97M
USD
Completed NON-SBIR/STTR RPGS
Targeting the autophagy-lysosome system to block pancreatic cancer
NATIONAL CANCER INSTITUTE University of California, San Francisco United States 2021 – 2026

PROJECT SUMMARY Cancer cells co-opt autophagy - an evolutionarily conserved cellular recycling pathway - to maintain metabolic fitness. Prior studies have shown that Pancreatic Duc...

$3.54M
USD
Completed NON-SBIR/STTR RPGS
Remodeling of 3D chromatin in B cell acute leukemia and its impact on clinical outcome
NATIONAL CANCER INSTITUTE New York University School of Medicine United States 2021 – 2026

ABSTRACT While the outcomes for children with acute lymphoblastic leukemia (ALL) have improved dramatically over the past four decades, major challenges remain including the burden...

$4.16M
USD
Completed NON-SBIR/STTR RPGS
Defining the role of BARD1 in nucleosomal ubiquitylation
NATIONAL CANCER INSTITUTE University of Washington United States 2021 – 2026

PROJECT SUMMARY BARD1 (BRCA1-Associated RING Domain protein-1) is an essential partner of the breast and ovarian cancer tumor-suppressor protein, BRCA1, and is included in a panel...

$5.11M
USD
Completed OTHER RESEARCH-RELATED
Elucidating Human Leukemia and T Cell Interactions within the Tumor Microenvironment
NATIONAL CANCER INSTITUTE University of Tx Md Anderson Can Ctr United States 2021 – 2025

Project Summary/Abstract Leukemic relapse remains the major obstacle to successful allogeneic stem cell transplantation (allo-SCT). Here, donor lymphocyte infusion (DLI) seeks to r...

$2.18M
USD
Completed OTHER RESEARCH-RELATED
Expanding the scope of protein degradation and stability using chemoproteomic platforms
NATIONAL CANCER INSTITUTE J. David Gladstone Institutes United States 2021 – 2024

Targeted protein degradation (TPD) has arisen as a powerful drug discovery platform for tackling the undruggable proteome by targeting specific proteins for proteasomal degradation...

$991.2K
USD
Completed TRAINING, INDIVIDUAL
T cell expressed miR-155 promotes antitumor immunity and immune checkpoint blockade responses in colon cancer through repression of Ship1
NATIONAL CANCER INSTITUTE University of Utah United States 2021 – 2026

PROJECT SUMMARY/ABSTRACT Colorectal cancer (CRC) is the second deadliest cancerglobally and has the third-highest incidenceand mortality rate of all cancers in the United States. P...

$569.7K
USD
Completed NON-SBIR/STTR RPGS
Mobile Contingency Management for Smoking Cessation among Socioeconomically Disadvantaged Adults
NATIONAL CANCER INSTITUTE University of Oklahoma Hlth Sciences Ctr United States 2021 – 2026

Project Summary Although smoking prevalence has declined to 13.7% among U.S. adults, smoking rates are much higher among socioeconomically disadvantaged adults. Lung cancer, which...

$5.77M
USD
Completed NON-SBIR/STTR RPGS
The Adenosinergic Pathway in Tumor-derived Exosomes
NATIONAL CANCER INSTITUTE University of Pittsburgh At Pittsburgh United States 2021 – 2026

PROJECT SUMMARY/ABSTRACT Tumor cells produce and release large numbers of extracellular vesicles (EVs). A subset of small (30-150 nm) EVs derived from the endocytic compartment of...

$4.78M
USD
Completed NON-SBIR/STTR RPGS
Modeling cancer risk and environmental and socio-spatial exposures using residential histories
NATIONAL CANCER INSTITUTE Virginia Commonwealth University United States 2021 – 2025

In many studies on the risk of disease, investigators analyze the spatial patterns of health outcomes and evaluate residential environmental exposures at the time of study enrollme...

$1.72M
USD
Completed NON-SBIR/STTR RPGS
Molecular Pathogenesis and Therapy of Systemic Histiocytic Neoplasms
NATIONAL CANCER INSTITUTE Sloan-Kettering Inst Can Research United States 2021 – 2026

Project Summary Histiocytic neoplasms are clonal disorders of the monocyte/macrophage lineage that include Langerhans Cell Histiocytosis (LCH), Erdheim-Chester Disease (ECD), Juven...

$5.26M
USD
Completed NON-SBIR/STTR RPGS
Pre-malignant mutation landscape and risk factors for progression to hematologic cancers
NATIONAL CANCER INSTITUTE Weill Medical Coll of Cornell Univ United States 2021 – 2026

ABSTRACT Clonal hematopoesis (CH) defined as the presence of acquired mutations detectable in peripheral blood of normal healthy individuals without hematologic malignancies (HM) h...

$5.95M
USD
Completed NON-SBIR/STTR RPGS
Elucidating pro-metastatic collagen modifying activities of lysyl hydroxylase 2
NATIONAL CANCER INSTITUTE University of Tx Md Anderson Can Ctr United States 2021 – 2026

As they progress, malignant tumors accumulate cross-linked collagen fibrils that enhance matrix stiffness, thereby activating collagen receptors that trigger cancer cell invasion a...

$5.24M
USD
Completed NON-SBIR/STTR RPGS
Lung Resident Mesenchymal Cells in the Pre-Metastatic Niche Formation
NATIONAL CANCER INSTITUTE Jackson Laboratory United States 2021 – 2026

PROJECT SUMMARY/ABSTRACT Metastatic disease remains the major cause of cancer-related death. Among the vital organs to which solid tumors metastasize, the lung is one of the most c...

$4.6M
USD
Completed NON-SBIR/STTR RPGS
Targeting replication stress signaling to overcome immune evasion in small cell lung cancer
NATIONAL CANCER INSTITUTE Icahn School of Medicine At Mount Sinai United States 2021 – 2026

New therapeutic strategies are urgently needed to improve immune checkpoint blockade (ICB) therapy in small cell lung cancer (SCLC). SCLCs rely heavily on the replication stress re...

$4.66M
USD
Completed NON-SBIR/STTR RPGS
Mechanistic maps of adaptive responses to therapeutic stress to optimize combination therapies.
NATIONAL CANCER INSTITUTE Oregon Health & Science University United States 2021 – 2026

Summary. In triple-negative breast cancer and high-grade serous ovarian cancer, the emergence of resistance to therapy is virtually inevitable and contributes to dismal long-term p...

$5.02M
USD